| 000 | 01838 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516115727.0 | ||
| 264 | 0 | _c20130730 | |
| 008 | 201307s 0 0 eng d | ||
| 022 | _a1537-6591 | ||
| 024 | 7 |
_a10.1093/cid/cis920 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJacobson, Karen R | |
| 245 | 0 | 0 |
_aImplementation of genotype MTBDRplus reduces time to multidrug-resistant tuberculosis therapy initiation in South Africa. _h[electronic resource] |
| 260 |
_bClinical infectious diseases : an official publication of the Infectious Diseases Society of America _cFeb 2013 |
||
| 300 |
_a503-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntitubercular Agents _xtherapeutic use |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMicrobial Sensitivity Tests _xmethods |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMycobacterium tuberculosis _xdrug effects |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 | _aSouth Africa |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTuberculosis, Multidrug-Resistant _xdiagnosis |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aTheron, Danie | |
| 700 | 1 | _aKendall, Emily A | |
| 700 | 1 | _aFranke, Molly F | |
| 700 | 1 | _aBarnard, Marinus | |
| 700 | 1 | _avan Helden, Paul D | |
| 700 | 1 | _aVictor, Tommie C | |
| 700 | 1 | _aStreicher, Elizabeth M | |
| 700 | 1 | _aMurray, Megan B | |
| 700 | 1 | _aWarren, Robin M | |
| 773 | 0 |
_tClinical infectious diseases : an official publication of the Infectious Diseases Society of America _gvol. 56 _gno. 4 _gp. 503-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/cid/cis920 _zAvailable from publisher's website |
| 999 |
_c22205969 _d22205969 |
||